Cantor Fitzgerald Reiterates Intellia Therapeutics (NTLA) Overweight Recommendation
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
Fintel reports that on August 29, 2023, Cantor Fitzgerald reiterated coverage of Intellia Therapeutics (NASDAQ:NTLA) with a Overweight recommendation.
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1683553525-6de999cabb614c0982df9166e8248583.jpg "5 by 5 Power: What It Means, How It Works")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1028780494-bca4e377fc0945edac0467b7afbf6f93-1685eed3fb4c45d48e3ab0718c8837aa.jpg "Calculate Your Debt-to-Income Ratio")
